Get started
Author

Geoff Chong

Dual Targeting of the Epidermal Growth Factor Receptor Using the Combination of Cetuximab and Erlotinib: Preclinical Evaluation and Results of the Phase II DUX Study in Chemotherapy-Refractory, Advanced Colorectal Cancer
2012 · Andrew J. Weickhardt, Tim J. Price, et al. · Journal of Clinical Oncology · 113
PDF
Hodgkin lymphoma: an Australian experience of ABVD chemotherapy in the modern era
2016 · Azim Jalali, Francis J. Ha, et al. · Annals of Hematology · 30
Immune Priming with Single-Agent Nivolumab Followed By Combined Nivolumab & Rituximab Is Safe and Efficacious for First-Line Treatment of Follicular Lymphoma; Interim Analysis of the '1st FLOR' Study
2019 · Allison Barraclough, Geoff Chong, et al. · Blood · 14
Tumour cell surface antigen targeted therapies in B-cell lymphomas: Beyond rituximab
2016 · Matthew Ku, Geoff Chong, et al. · Blood Reviews · 14
Early Treatment Intensification with R-ICE Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) Using Zevalin-BEAM for Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL) As Identified By Interim PET/CT Scan Performed after Four Cycles of R-CHOP-14: A Multicenter Phase II Study of the Australasian Leukaemia Lymphoma Study Group (ALLG)
2015 · Mark S Hertzberg, Maher K Gandhi, et al. · Blood · 8
Occult Gastrointestinal Perforation in a Patient With EGFR-Mutant Non–Small-Cell Lung Cancer Receiving Combination Chemotherapy With Atezolizumab and Bevacizumab: Brief Report
2019 · Ashray Gunjur, Geoff Chong, et al. · Clinical Lung Cancer · 6
A Practical Approach to the Use of Conventional Synthetic, Biologic and Targeted Synthetic Disease Modifying Anti-Rheumatic Drugs for the Treatment of Inflammatory Arthritis in Patients with a History of Malignancy
2018 · Peter K. K. Wong, Hanish Bagga, et al. · Current Rheumatology Reports · 6
Limited utility of routine chest X‐ray in initial evaluation of neutropenic fever in patients with haematological diseases undergoing chemotherapy
2017 · Ortis Estacio, Zoe Loh, et al. · Internal Medicine Journal · 6
PDF
Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression
2020 · Oliver A. Piercey, Zoe Loh, et al. · JCO Oncology Practice · 5
Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency
2024 · Colin Williams, Geoff Chong, et al. · Asia-Pacific Journal of Clinical Oncology · 4
AvR-CHOP: Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
2019 · Eliza A Hawkes, Kate Manos, et al. · Blood · 3
Results From the Safety Run‐in Period of the Sympatico Study Evaluating Ibrutinib in Combination With Venetoclax in Patients With Relapsed/refractory Mantle Cell Lymphoma
2019 · M. Wang, R. Ramchandren, et al. · Hematological Oncology · 3
Perioperative therapy for resectable gastric cancer: What does the future hold?
2011 · Geoff CHONG, Niall C TEBBUTT · Asia-Pacific Journal of Clinical Oncology · 3
PDF
Phase I Dose Escalation Study of Radiotherapy and Durvalumab (MEDI4736) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): The RaDD Study
2019 · Eliza A Hawkes, Kate Manos, et al. · Blood · 2
Echocardiography has low utility in cancer patients with Staphylococcus aureus bacteraemia: findings from a retrospective study
2018 · Zoe Loh, Ortis Estacio, et al. · Supportive Care in Cancer · 2
Real-World Treatment and Outcomes for Patients With Deficient Mismatch Repair Metastatic Colorectal Cancer Following Pembrolizumab Availability in Australia
2026 · Grace Y. Kim, Vanessa Wong, et al. · Clinical Colorectal Cancer
Toxicity Under-Reporting in Early-Phase Plasma Cell Dyscrasia Clinical Trial Abstracts
2026 · Dawn Swan, Marsali Maclean, et al. · JCO Oncology Practice
The gut microbiome in B cell lymphoma
2025 · Darcy Vickers, Arina Martynchyk, et al. · Blood Reviews
Exploring the association between Cultural and Linguistic Diversity (CALD) on treatment and outcomes in pancreatic cancer: an analysis of PURPLE real-world registry data from an Australian population
2025 · Emma Sanderson, Belinda Lee, et al. · BMC Public Health
PDF
192 | Follicular Lymphoma Displays Distinct Gene Expression Profiles According to Histological Grade
2025 · A. Barraclough, E. A. Hawkes, et al. · Hematological Oncology
PDF
Real world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer.
2024 · Vanessa Wong, Matthew Loft, et al. · Journal of Clinical Oncology
PDF
Trial in Progress: Treatment of Newly-Diagnosed Follicular Lymphoma with Celmod BMS-986369, Rituximab +/- Nivolumab: An Umbrella Phase II Investigator-Initiated Study
2023 · Geoff Chong, Jodie B Palmer, et al. · Blood
PDF
Interim 3‐Dimensional volumetric response (3DVR) is associated with better overall survival of patients (pts) with primary central nervous system lymphoma (PCNSL)
2023 · A. Martynchyk, J. O'Shaughnessy, et al. · Hematological Oncology
PDF
T cell CD62L expression following nivolumab therapy is associated with response to rituximab‐nivolumab in treatment naïve follicular lymphoma: the 1st FLOR study
2023 · R. M. Koldej, A. Barraclough, et al. · Hematological Oncology
PDF
A Multicenter Retrospective Review of Outcomes of Diffuse Large B Cell Lymphoma (DLBCL) in the Elderly Treated with RCHOP in Australia
2017 · Michael Ashby, Eliza A. Hawkes, et al. · Blood
Works count: 28
Citation count: 219
H-index: 6
I10-index: 4
Year
Topic
Type